Fig. 5From: Bone targeting compounds for radiotherapy and imaging: *Me(III)-DOTA conjugates of bisphosphonic acid, pamidronic acid and zoledronic acidWhole body scintigraphy 1 h after administration of [177Lu]DOTAZOL. The compound shows strong accumulation in the bone, and in particular in the high metabolic epiphyseal plates and other joint regions (the same effect was observed for the 68Ga-bisphosphonates)Back to article page